Culture medium, method for inducing differentiation of adipose-derived stem cells into myoblasts
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- BIOFUTURE TECH LTD
- Filing Date
- 2026-01-08
- Publication Date
- 2026-06-16
AI Technical Summary
【0007】 この発明は、間葉系幹細胞からPax7の発現を促し、効果的に筋芽細胞に分化誘導できる培地を提供できる。この発明は、そのような培地を用いて間葉系幹細胞を筋芽細胞へと分化誘導する方法を提供できる。
Smart Images

Figure 0007874379000001_ABST
Abstract
Claims
1. A basic medium comprising serum, IMDM (Iscove's Modified Dulbecco's Medium) medium in an amount of 2 to 8 times the volume of the serum, and Ham's F-12 (Ham's Nutrient Mixture F-12) medium in an amount of 2.5 to 10 times the volume of the serum, Dexamethasone with a concentration of 0.25 mM or more and 1 mM or less, A culture medium for inducing the differentiation of mesenchymal stem cells into myoblasts, containing insulin at a concentration of 10 ng / mL to 50 ng / mL.
2. A culture medium according to claim 1, The basic culture medium is a culture medium comprising IMDM medium in an amount of 3 to 6 times the volume of the serum and Ham's F-12 medium in an amount of 4 to 7 times the volume of the serum.
3. A method for producing myoblasts, which includes a differentiation induction step in which mesenchymal stem cells are differentiated into myoblasts, The differentiation induction step includes a resting step, which is a step of suspending mesenchymal stem cells in the medium described in claim 1 and culturing them in a static environment at 4°C or higher and 10°C or lower for 1 day or more and 4 days or less to obtain a culture.
4. The method according to claim 3, The differentiation induction step further comprises a post-culturing step, which, after the standing step, involves seeding the culture into a culture vessel and culturing it in serum medium or the medium described in claim 1 for 4 days to 2 weeks.
5. The method according to claim 4, A method comprising the above-mentioned standing step and the above-mentioned post-culturing step, wherein the expression of Pax7 and muscle-specific gene group MRFs is induced.
6. A method according to claim 5, wherein the muscle-specific gene group MRFs comprises Myf5, MyoD, Myogenin, and MRF4.